02407.HK
Gaush Meditech Ltd
HKSE · Healthcare · Medical - Devices · CN
HKD 4.57
−2.56%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.8B | 1.4B | 1.4B | 1.4B | 1.3B |
| Cost of Revenue | 1.5B | 747.2M | 765.0M | 714.6M | 628.4M |
| Gross Profit | 1.3B | 633.2M | 663.4M | 691.6M | 625.3M |
| Operating Expenses | |||||
| R&D Expense | 178.1M | 92.6M | 78.4M | 52.9M | 41.1M |
| SG&A Expense | 811.3M | 419.0M | 378.4M | 378.2M | 333.9M |
| General & Admin Expense | 246.1M | 174.2M | 145.5M | 129.4M | 146.2M |
| Selling & Marketing Expense | 362.2M | 244.8M | 232.9M | 248.8M | 187.8M |
| Other Expenses | — | — | (19.4M) | (18.6M) | (14.5M) |
| Total Operating Expenses | 989.4M | 511.6M | 437.4M | 412.4M | 360.5M |
| Cost and Expenses | 2.5B | 1.3B | 1.2B | 1.1B | 989.0M |
| Operating Income (EBIT) | 297.5M | 121.6M | 197.2M | 279.2M | 246.2M |
| Non-Operating | |||||
| Interest Income | 5.9M | 2.5M | 3.2M | 6.6M | 4.7M |
| Interest Expense | 41.1M | 19.6M | 36.7M | 50.6M | 42.7M |
| Net Interest Income | (38.7M) | (17.1M) | (33.5M) | (44.0M) | (38.0M) |
| Other Non-Op Income/Expense | (48.6M) | (7.0M) | (41.9M) | (31.4M) | (521.3M) |
| Non-Operating Income (excl Interest) | 13.8M | 9.0M | 12.1M | (19.2M) | — |
| EBT (Pre-Tax Income) | 249.0M | 114.7M | 155.3M | 247.7M | (275.1M) |
| Income Tax Expense | 81.1M | 23.5M | 66.8M | 74.8M | 77.6M |
| Bottom Line | |||||
| Net Income | 177.4M | 96.2M | 92.4M | 173.5M | (349.6M) |
| Earnings from Cont. Ops | 167.9M | 91.2M | 88.5M | 172.9M | (352.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 177.4M | 96.2M | 92.4M | 173.5M | (349.6M) |
| Per Share | |||||
| Basic EPS | HK$1.22 | HK$0.66 | HK$0.63 | HK$1.17 | (HK$3.61) |
| Diluted EPS | HK$1.22 | HK$0.66 | HK$0.63 | HK$1.17 | (HK$3.61) |
| Revenue Per Share | HK$19.32 | HK$9.51 | HK$9.66 | HK$9.50 | HK$12.93 |
| Shares | |||||
| Basic Shares Outstanding | 143.0M | 145.1M | 147.8M | 148.0M | 96.9M |
| Diluted Shares Outstanding | 143.0M | 145.1M | 147.8M | 148.0M | 96.9M |
| Profitability Metrics | |||||
| EBITDA | 369.3M | 169.7M | 247.3M | 374.3M | 271.9M |
| D&A | 85.5M | 57.1M | 52.8M | 76.0M | 44.9M |
| EBIT | 283.8M | 112.6M | 194.5M | 298.3M | 227.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026